7 recruiting, 5 completed, 5 not yet recruiting, 1 active not recruiting. 9 Not applicable, 3 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 9 | Completed 3, Not yet recruiting 3, Recruiting 2, Active not recruiting 1 |
| Phase 2 | 3 | Recruiting 2, Completed 1 |
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Breast Cancers: new trials by email Literature Review of Breast Cancers trials Research Report on Breast Cancers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Partial Breast Re-irradiation for Breast Cancer Radiation Therapy - Breast Cancers | Not applicable | Active not recruiting | University Hospital Heidelberg | 20 | 2025-08-28 | 2026-10-13 |
| Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab - Breast Cancers | Not applicable | Recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 112 | 2025-08-15 | 2026-04-29 |
| Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer Pembrolizumab, Deescalation - Breast Cancers, Triple Negative Breast Cancer (TNBC) | Phase 3 | Recruiting | UNICANCER | 2454 | 2025-07-23 | 2026-07-23 |
| EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers SERS detection - Sentinel Lymph Node, Breast Cancers | Not yet recruiting | Yunnan Cancer Hospital | 40 | 2025-06-15 | 2025-06-12 | |
| Prediction of ICG for Skin Necrosis in Mastectomy With Immediate Reconstruction Breast Cancers, Mastectomy and Breast Reconstruction | Not yet recruiting | University Medical Center Groningen | 50 | 2025-06-01 | 2025-05-04 | |
| Breast Cancer PET/CT Imaging With 68Ga-pAKTi 68Ga-pAKTi PET/CT probe - Breast Cancers, PIK3CA Mutation-Related Tumors | Enrolling by invitation | Fudan University | 20 | 2025-04-21 | 2025-04-24 | |
| Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada Group Exercise Classes - Cancer, Prostate Cancers | Not applicable | Recruiting | University of Calgary | 740 | 2025-03-11 | 2025-10-07 |
| A Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Hormone Receptor Positive Breast Cancer Patients Hyperbaric oxygen treatment - Breast Cancers | Not applicable | Not yet recruiting | Guangdong Provincial People's Hospital | 55 | 2025-02-15 | 2025-02-13 |
| A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Triple-Negative and HER2+ Breast Cancer Patients Hyperbaric oxygen treatment - Breast Cancers | Not applicable | Not yet recruiting | Guangdong Provincial People's Hospital | 348 | 2025-02-12 | 2025-02-13 |
| Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs hyperbaric oxygenation treatment, routine care - Breast Cancers | Not applicable | Not yet recruiting | Guangdong Provincial People's Hospital | 226 | 2025-02-05 | 2025-02-11 |
| A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer Patients hyperbaric oxygen treatment - Breast Cancers | Phase 1 / Phase 2 | Recruiting | Guangdong Provincial People's Hospital | 161 | 2025-02-01 | 2025-04-01 |
| Tirzepatide Weight Loss for MRD+ Early Breast Cancer Tirzepatide - Breast Cancer, Breast Neoplasms | Phase 2 | Recruiting | Baylor Research Institute | 48 | 2024-11-26 | 2026-02-12 |
| Study on Sleep, Lifestyle and Quality of Life in Women With Breast Cancer Patients reported outcomes, questionnaire global Pittsburgh Sleep Quality Index (PSQI) - Breast Cancers | Completed | Institut Rafael | 60 | 2023-06-01 | 2024-10-30 | |
| Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study Palbociclib, Ribociclib, Abemaciclib - Breast Adenocarcinoma, Breast Cancer Stage IV | Recruiting | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 3500 | 2023-05-01 | 2025-02-03 | |
| Examining the Effectiveness of Multidisciplinary Care Teams in Improving Outcomes for Breast Cancer Patients Multidisciplinary Care Team (MDCT) Approach, Standard Breast Cancer Therapy - Breast Cancers, Breast Cancer Female | Not applicable | Completed | Yousaf Jan | 73 | 2021-05-01 | 2025-03-07 |
| Dendritic Cell Vaccination for Patients with Solid Tumors autologous dendritic cell vaccination - Glioblastoma, Renal Cell Carcinoma | Phase 1 / Phase 2 | Completed | University Hospital, Antwerp | 48 | 2010-05-03 | 2024-12-09 |
| The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers Mindfulness based meditation program - Breast Cancers, Gynecologic Cancer | Not applicable | Completed | Weill Medical College of Cornell University | 94 | 2003-05-01 | 2017-02-23 |
| Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies Ultrasound Scan, Mammography and Ultrasound - Breast Cancers | Not applicable | Completed | University of Michigan | 88 | 2000-03-01 | 2016-05-05 |
| Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation Questionnaires - Breast Cancers, Ovarian Cancers | Recruiting | Institut Paoli-Calmettes | 5000 | 1999-10-15 | 2026-10-14 |
Breast Neoplasms (19) · Neoplasm Metastasis (2) · Anxiety Disorders (1) · Breast Diseases (1) · Breast Neoplasms, Male (1) · Carcinoma, Renal Cell (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Depression (1) · Glioblastoma (1) · Lung Neoplasms (1) · Margins of Excision (1) · Mesothelioma, Malignant (1) · Motor Activity (1) · Necrosis (1)
Neoplasms by Site (19) · Skin Diseases (19) · Skin and Connective Tissue Diseases (19) · Breast Diseases (18) · Neoplasms (18) · Pathological Conditions, Signs and Symptoms (4) · Pathologic Processes (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Behavior (2) · Colonic Diseases (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2)
Surveys and Questionnaires (2) · High-Energy Shock Waves (1) · Meditation (1) · Paclitaxel (1) · Patient Care Team (1) · Radiotherapy (1) · Standard of Care (1) · Tirzepatide (1) · Trastuzumab (1) · abemaciclib (1) · palbociclib (1) · pembrolizumab (1) · pertuzumab (1) · ribociclib (1)
Guangdong Provincial People's Hospital (4) · Baylor Research Institute (1) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · Fudan University (1) · Institut Paoli-Calmettes (1) · Institut Rafael (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · UNICANCER (1) · University Hospital Heidelberg (1) · University Hospital, Antwerp (1) · University Medical Center Groningen (1) · University of Calgary (1) · University of Michigan (1) · Weill Medical College of Cornell University (1) · Yousaf Jan (1)
China (7) · France (3) · United States (3) · Belgium (2) · Canada (1) · Germany (1) · Italy (1) · Pakistan (1)
Joana Mourato Ribiero (1) · Joseph Loizzo, MD,PhD (1) · Joyce A O'Shaughnessy, MD (1) · Juergen Debus, MD (1) · Kun Wang, PhD (1) · Mary E Charlson, MD (1) · Nicole Culos-Reed, PhD (1) · Paul Carson, PhD (1) · Paul L. Carson, Ph.D. (1) · Qiang Liu, PhD (1) · Yousaf Jan, MBBS, FCPS, FRCS, MRCS, ECFMG (1)
PMID 15171047, PMID 15368961, PMID 16622123, PMID 16801631, PMID 17416765, PMID 17635951, PMID 19190154, PMID 19751997, PMID 21248744, PMID 21708517, PMID 21761160, PMID 22076253, PMID 22378286, PMID 22762150, PMID 22956590, PMID 23475556, PMID 24889689, PMID 25010056, PMID 25455630, PMID 25550141, PMID 25613119, PMID 26205609, PMID 28632866, PMID 30873510, PMID 31360853, PMID 31505944, PMID 31792088, PMID 31948486, PMID 32102695, PMID 32665703, PMID 34325649, PMID 37369040
P01CA087634 (1)